Native Antigen Company wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards
The Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at the OBN 2020 Awards. The award recognises the company’s outstanding contribution to the fight against COVID-19.
